Community Health Centers of SE IA Inc West Burlington
-
Services:
- Vaping not permitted
- Case management service
- Mental health services
- Early intervention for HIV
- Integrated primary care services
- Suicide prevention services
- Specially designed program for DUI/DWI clients
- This facility administers/prescribes medication for alcohol use disorder
- Naltrexone (oral)
- Acamprosate (Campral®)
- Nicotine replacement
- Medications for pre-exposure to prophylaxis
- Non-nicotine smoking/tobacco cessation
- Naltrexone (extended-release, injectable)
- Buprenorphine (extended-release, injectable)
- Medications for HIV treatment
- Buprenorphine with naloxone
- Medication for mental disorders
- Medications for Hepatitis C treatment
- Clonidine
- Disulfiram
- Buprenorphine without naloxone
- Marital/couples counseling
- Individual counseling
- Smoking/vaping/tobacco cessation counseling
- Substance use disorder education
- HIV or AIDS education, counseling, or support
- Hepatitis education, counseling, or support
- Health education services other than HIV/AIDS or hepatitis
- Family counseling
- Seniors
- Adults
- Drug or alcohol urine screening
- Testing for Hepatitis C (HCV)
- Metabolic syndrome monitoring
- STD testing
- HIV testing
- TB screening
- Testing for Hepatitis B (HBV)
- Smoking not permitted
- Sliding fee scale (fee is based on income and other factors)
- Private non-profit organization
- Assistance with obtaining social services
- Housing services
- Professional interventionist/educational consultant
- Complete medical history/physical exam
- Screening for mental disorders
- Comprehensive mental health assessment
- Screening for tobacco use
- Outreach to persons in the community
- Interim services for clients
- Comprehensive substance use assessment
- Screening for substance use
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Substance use treatment
- Hepatitis A (HAV) vaccination
- Hepatitis B (HBV) vaccination
- State Substance use treatment agency
- Federally Qualified Health Center
- State mental health department
- State department of health
- Male
- Female
- Prescribes naltrexone
- Maintenance service with medically supervised withdrawal after stabilization
- Relapse prevention with naltrexone
- Prescribes buprenorphine
- Buprenorphine maintenance
- State-financed health insurance plan other than Medicaid
- Cash or self-payment
- Medicare
- Private health insurance
- Medicaid
- Federal military insurance (e.g., TRICARE)
- Community reinforcement plus vouchers
- Trauma-related counseling
- Relapse prevention
- 12-step facilitation
- Cognitive behavioral therapy
- Brief intervention
- Substance use disorder counseling
- Motivational interviewing
- Telemedicine/telehealth therapy
- Contingency management/motivational incentives
- Anger management
- Sign language services for the deaf and hard of hearing
- In-network prescribing entity
- Outpatient methadone/buprenorphine or naltrexone treatment
- Outpatient
- Regular outpatient treatment
- Intensive outpatient treatment
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
- Discharge Planning
- Aftercare/continuing care
- Outcome follow-up after discharge
- Naloxone and overdose education
Facility Vaping Policy
Ancillary Services
Exclusive Services
Type of Alcohol Use Disorder Treatment
Pharmacotherapies
Education and Counseling Services
Age Groups Accepted
Testing
Facility Smoking Policy
Payment Assistance Available
Facility Operation (e.g., Private, Public)
Recovery Support Services
Assessment/Pre-treatment
Type of Care
Medical Services
License/Certification/Accreditation
Gender Accepted
Type of Opioid Treatment
Payment/Insurance/Funding Accepted
Treatment Approaches
Language Services
External Source of Medications Used for Alcohol Use Disorder Treatment
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Opioid Medications used in Treatment
Transitional Services